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ABSTRACT 
We describe here a platform for high-throughput protein expression and interaction analysis 
aimed at identifying the RNA-interacting domainome. This approach combines the selection of 
a phage library displaying “filtered” open reading frames with next-generation DNA sequencing. 
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The method was validated using an RNA bait corresponding to the AU-rich element of -
prothymosin, an RNA motif that promotes mRNA stability and translation through its 
interaction with the RNA-binding protein ELAVL1. With this strategy, we not only confirmed 
known RNA-binding proteins that specifically interact with the target RNA (such as ELAVL1/HuR 
and RBM38) but also identified proteins not previously known to be ARE-binding (R3HDM2 and 
RALY). We propose this technology as a novel approach for studying the RNA-binding 
proteome. 
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LIST OF ABBREVIATIONS 
ARE: AU-rich element; 
BSA: bovine serum albumin; 
CFU: colony-forming unit; 
ELISA: enzyme-linked immunosorbent assay; 
MS: mass spectrometry; 
O/N; overnight; 
ORF: open reading frame; 
PBS: phosphate-buffered saline; 
RBD: RNA-binding domain; 
RBP: RNA-binding protein; 
RBPome: RNA-binding proteome; 
RT: room temperature; 
SPR: surface plasmon resonance. 
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INTRODUCTION 
In recent years, the RNA world has expanded tremendously as a huge array of new RNA 
molecules have been discovered through transcriptome analyses (reviewed in 1, 2). The vast 
majority of these RNAs lack the features that are typically considered to predict protein-coding 
capability 3 and are therefore globally classified as non-coding RNAs (ncRNAs). Although non-
coding, many of them play fundamental roles in numerous biological processes, ranging from 
gene expression regulation and epigenetic modifications to RNA processing and translation 
(reviewed in 4). These findings are not surprising because it is now well known that many and 
diverse RNAs, including messenger (m)RNAs, can perform biological tasks by virtue of their 
ability to adopt complex secondary and tertiary structures. In the cell, these are targets of RNA-
binding proteins (RBPs) 5 that mediate the assembly of functional ribonucleoprotein complexes 
(RNPs). Therefore, there have been intensive efforts to develop in vitro and in vivo methods to 
identify and profile the cohort of RBPs associated with RNAs of interest (reviewed in 6). These 
methods are based on a similar concept that uses specific RNA sequences to bait interacting 
RBPs that are then identified by specific reagents or by mass spectrometry (MS). 
Recent updates to these approaches have extended the analysis to complex mixtures of 
transcripts, such as polyadenylated RNAs, allowing previously unprecedented views of the 
complexity and dynamics of RNA-protein interactions 7, 8. Nevertheless, the number of RBPs 
that have so far been associated with given transcripts is still a minor fraction of the entire 
predicted RNA-binding proteome (RBPome). This is likely due to some caveats of these 
approaches. The procedures consist of elaborate, multistep processes that require optimization 
and affinity reagents to purify the desired RNP complexes. Moreover, because of the sensitivity 
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limitations of MS, RNPs composed of low-abundance RNAs and/or RBPs tend to be 
underrepresented 9, while proteins with low-complexity sequences are overrepresented 10. 
In principle, some of these limitations (e.g., poorly expressed RBPs) could be overcome by 
approaches based on the screening of protein libraries, with the advantage of coupling 
phenotype to genotype identification. 
Several methods have been proposed to work in vivo 11-13 or in vitro 14-16. Generally, they use 
any format of protein library that can faithfully represent the full-length proteome of interest, 
either as an array of candidate proteins or as products of selected open reading frame (ORF) 
libraries. However, these methods are burdened by the effects of screening modes and 
contests on protein stability and folding, particularly when full-length proteins are tested 17, 18. 
These problems could be solved, or considerably attenuated, given the chance to select 
correctly folded and active proteins domains. Due to their smaller size and conserved structural 
folding 19, protein domains can be independently expressed while preserving their individual 
functions 20. Thus, screening a library that faithfully represents most or all of the functional 
domains encoded by a genome (domainome), could provide a simple method to annotate gene 
products, including those encoding RBPs. 
In previous works, we have demonstrated that applying β-lactamase-based filtering to 
randomly fragmented DNA or cDNA from diverse sources makes it possible to generate phage-
display libraries enriched for genic ORFs 21-23. We believe this is because only fragments of 
functional ORFs can form foldable domains that do not adversely affect the folding and activity 
of the fused β-lactamase reporter protein. Random ORFs do not fold into coherent domains 
and lead to the aggregation, misfolding and inactivation of the folding reporter. When 
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combined with next-generation sequencing (NGS), as a way to analyze their complexity, these 
libraries are used as universal reagents that can be screened for several activities, including 
rapid interactome profiling 23, 24. In accordance with this assumption, we wanted to evaluate 
whether such an approach could add power to the field of RNA-protein interaction discovery. 
Here, we show that by screening a human cDNA-derived ORF library with the AU-rich element 
(ARE) from the α-prothymosin (PTMA) mRNA, a well characterized RNA structure 25, we 
succeeded in selecting a panel of RNA-binding domains (RBDs) ascribable to proteins known to 
bind ARE motifs, such as ELAVL1 and RBM38, and also including other proteins not previously 
known to be ARE-binding proteins (ARE-BPs), such as R3HDM2 and RALY. Overall, our method 
provides a simple and fast means to identify RBPs for a target RNA, independent of their 
relative abundance. 
RESULTS 
This work stems from previous studies in which we succeeded in profiling the interactomes of 
single or complex mixtures of proteins 23, 24 using a platform that combines ORF phage display 
library selection with NGS analysis. Encouraged by these results, we decided to exploit the 
power of this platform for revealing RNA-protein interactions. 
RIDome pipeline overview 
The RNA Interacting Domainome (RIDome) pipeline features the following key steps, outlined 
in Figure 1A: 
(1) Selection of ORFs binding to a target RNA. ORF-displaying phages are challenged with a 
biotinylated RNA bait through two cycles of selection and amplification. 
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(2) Massive sequencing of selected phage inserts and ranking of corresponding genes. ORF 
inserts are recovered from selected phages and sequenced by NGS, and the corresponding 
genes are ranked according to read frequency. 
(3) Recovery and validation of the top-ranking ORFs in vitro. High-scoring ORFs are recloned 
from the library by inverse PCR, and their interactions with the target are validated in vitro by 
ELISA- and Surface Plasmon Resonance (SPR)-based assays. 
(4) Validation of the interacting ORFs in vivo. RNA-binding ORFs are subcloned into a 
compatible mammalian expression vector and co-transfected into mammalian cells with a 
reporter DNA construct harboring the target sequence. The interactions are confirmed by RNA 
immunoprecipitation and functional assays. 
RBPome coverage. 
As a proof of principle, we first assessed the extent of the predicted RBPome covered by our 
ORF library. For this purpose, we used library sequencing data that had been collected in 
previous and ongoing studies (Additional File 1) and compared those data to the largest dataset 
of RNA-binding proteins recently published by Gerstberger S. et al 26. Although presumably not 
exhaustive, this dataset includes 1542 experimentally and/or computationally predicted RBPs, 
and of these, we found that 1497 RBPs (> 97%) are represented by at least one read in our 
library (Figure 2A). The same database also contains a census of 1704 transcription factors 
(TFs), a protein family numerically similar to RBPs. Similarly, we found that 1672 TFs are 
represented by at least one read in our library, corresponding to > 98% of TFs annotated in the 
database (Figure 2A). These findings are consistent with data obtained by the thorough 
characterization of the library (unpublished results) and support the concept that coupling β-
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lactamase-based filtering to phage display enriches for genic rather than spurious ORFs, which 
is a prerequisite of selecting for functional domains. 
Library screening and the identification of ARE-interacting domains. 
After assessing the RBPome coverage of the library, we decided to screen it using the AU-rich 
element (ARE), a well-characterized RNA sequence, as bait. ARE is a functional element found in 
the 3′-untranslated regions (UTRs) of many mRNAs, and it is known as the most common 
determinant of RNA stability in mammalian cells 27. Although little sequence similarity is shared 
by different AREs, they generally contain an AUUUA motif embedded in U-rich sequences 28 and 
are predicted to fold in stem-loop structures (Figure 1B) 28, 29. We chose the ARE from the α-
prothymosin mRNA (AREPTMA) because it is a well-defined element 25 predicted to fold in a 
stable, bulge-less stem-loop structure (Figure 1B) that is known to be a target of RBPs in vitro 
and in vivo 25, 30. The sequence was synthesized as 3’-biotinylated RNA 24mers and used in the 
discovery pipeline. As a control, we synthesized a mutant (AREmutPTMA) predicted to not fold in 
a stable stem-loop structure (Figure 1B). 
The library selection was performed as reported 31, 32 with minor changes of solutions 
composition to safeguard the RNA bait (see the Materials and Methods section). After two 
cycles of selection, phagemid DNAs were recovered, and ORF inserts were amplified and 
sequenced according to a 454 protocol. To limit the time-consuming analysis of large amounts 
of data, we decided to sequence a minimal fraction of the selection output, sufficient to contain 
an overview of the most likely repertoire of ARE-interacting ORFs. We obtained 71116 reads 
that were analyzed with the NGS Transcriptome profile explorer (NGS-Trex) system 33 and 
mapped onto the human genome (NCBI build 36). Sequences matching annotated genes were 
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then ranked as described 31, and the resulting list comprised 4971 genes (Additional File 1). 
Using a frequency of representation higher than 1/1000 reads as the cut off, only 36 genes 
were identified (Additional File 1). Redundantly mapped genes (DUXs, MTNDP4P12, 
MTNDP5P11, OVCA2, and STX16-NPEPL1) were removed from the list. The specificity of 
selection was validated by comparing the list of genes to the RBP and TF databases. Not 
surprisingly, we found that although no TFs were present, 15 of the 36 genes were RBPs (Figure 
2B). 
Furthermore, we analyzed the identified genes for functional annotation using the Gene 
Ontology enRIchment anaLysis and visuaLizAtion tool (http://cbl-gorilla.cs.technion.ac.il) 34. We 
used the “two lists of genes” running mode, setting the gene list from the (N)on (S)elected 
library as the “background” and the list from the selection as the “target” set. GOrilla 
associated only 32 genes with a GO term because four genes (DUX4L6, BSDC1, H19 and 
LOC400550) were not in the GO database. We found that the genes ranked in our list were 
enriched in 18 GO terms (Figure 2C and Additional File 2), most of which (14 of the 18) referred 
to RNA-related processes, a finding that confirms the utility of our selection as a simple and 
straightforward method for obtaining an overview of the potential ARE-RIDome. 
Rescue and Validation of ARE-Interacting Domains in vitro. 
To verify the binding properties of the enriched ORFs, we recovered the clones corresponding 
to the top twelve listed genes. To this end, each top gene was first individually analyzed with 
the NGS-Trex tool, and a typical result window is shown in Figure 3 (ELAVL1 and R3HDM2 are 
given as two examples). For each mapped gene, NGS-Trex shows its genomic context, with all 
supporting reads aligned to the gene. The blue bars at the top of each panel represent the 
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genes, and the green boxes correspond to the exons (RefSeq mRNAs). From this analysis, it is 
possible to compare the supporting sequences obtained before (NS) and after selection. 
Particularly informative is the “focus index,” which represents the ratio between the depth of 
read coverage at the deepest site and the total number of reads per gene 33. The closer this 
ratio is to one, the more ‘focused’ the reads are to a single site or domain within the gene, 
while a lower index indicates a wider distribution of the reads on each gene. As shown for 
ELAVL1, a substantial increase in the focus index (from 0.385 to 0.755) was obtained, with most 
reads centered on exons 3 and 4 (Figure 3). Similarly, the focus index of R3HDM increased from 
0.554 to 0.975, with most reads spanning exons 5 to 8 (Figure 3). 
This analysis allowed us to exclude three top genes (highlighted in Additional File 1) because 
the corresponding fragments either were overrepresented in the NS library but not enriched by 
selection (H19) or did not correspond to annotated genic ORFs (MMP14 and DUX4L6). 
Candidate ORFs were rescued from the selected library by inverse PCR (see the Materials and 
Methods section). After transformation, eight clones from each ligation (96 clones in total) 
were randomly picked and grown in a multiwell plate, sequenced to confirm gene/ORF 
correspondence and then analyzed by phage ELISA on AREPTMA, AREmutPTMA and control targets. 
Among those tested, RBM38-, ELAVL1-, RALY- and R3HDM2-derived clones resulted in the most 
robust binding specificity (Figure 4A). RBM38 and ELAVL1 are RBPs known to bind AU-rich 
elements in several mRNA 3’ UTRs and to regulate their stability, splicing and translation. Their 
RNA-binding properties are mediated by conserved RNA recognition motifs (RRMs). These 
RRMs are present as a single module in RBM38 35 or as a bipartite module in ELAVL1, where 
two tandem N-terminal domains (RRM1 and RRM2) selectively bind ARE, while RRM3 interacts 
D
ow
nl
oa
de
d 
by
 [S
IS
SA
], 
[S
tef
an
o G
us
tin
cic
h]
 at
 01
:39
 24
 N
ov
em
be
r 2
01
5 
 
 
11 
 
with the poly(A) tail and other proteins 36. Furthermore, when the ORF inserts of tested clones 
were sequenced, we observed that these inserts faithfully represented the predicted RNA-
binding domains (Figure 4B). For instance, all tested ELAVL1-derived clones encoded the RRM1-
2 module, and no clones were found with different motif combinations (e.g., RRM1, RRM2 or 
RRM2-3), indicating that only the two N-terminal motifs can fold correctly and bind to the ARE 
sequence. This evidence is consistent with previous observations 31 and supports the power of 
our method for favoring the display of functional domains. 
Interestingly, RALY- and R3HDM2-derived clones were positive in phage ELISA (Figure 4A). RALY 
is a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family and is 
involved in pre-mRNA splicing and tumor development 37. RALY contains a single RRM at the N-
terminus, with binding properties that have not yet been defined. R3HDM2 is a large protein 
containing a conserved motif consisting of an invariant arginine and a highly conserved histidine 
that are separated by three residues (R3H motif). Structural studies have indicated that the R3H 
domain might be involved in interactions with single-stranded nucleic acids 38. None of these 
proteins had previously been shown to bind ARE sequences. Importantly, also in the case of 
RALY- and R3HDM2-derived phages, we observed that selected ORF sequences were limited to 
the corresponding binding domains (Figure 4B), further evidence of the functional constraint 
exerted by filtering. The other eight tested candidates either were negative by phage ELISA 
(RBMX2, MYH9, NPEPL1, PCBD2, MAP1A) or did not show binding specificity (TOP1, DNAJC7, 
EIF5B). 
To further confirm the binding properties of positive clones, we chose a representative ORF for 
each gene and subcloned it into a modified pGEX vector to produce GST-fusion products with C-
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terminal FLAG-tags. Proteins were expressed in E. coli, purified by glutathione affinity 
chromatography, and then assayed by ELISA on ARE targets or controls. As shown in Figure 4C, 
the selected domains of ELAVL1, RBM38, RALY and R3HDM2, but not those of EIF5B, were 
confirmed to specifically bind the AREPTMA target, indicating that their folding and activity was 
not due to the phage context. 
To directly compare the RNA-binding properties of ELAVL1-, RBM38-, RALY- and R3HDM2-
derived GST-fusion products, we used surface plasmon resonance (SPR) to measure both the 
affinity and kinetics of binding to the AREPTMA sequence (see the Materials and Methods 
section). As shown in Figure 5, all fusion products bound the AREPTMA RNA with a KD in the 
nanomolar range: RBM38 = 1 nM; ELAVL1 = 5 nM; R3HDM2 = 21 nM; and RALY = 55 nM. 
Because the binding properties of ELAVL1 to ARE targets have been characterized 39, 40, we 
wanted to compare these to the properties obtained with the GST-ORFELAVL1 product. Thus, we 
cloned the full-length coding sequence of ELAVL1 from HEK293 cells, expressed it in E. coli and 
performed SPR analyses as above. We also prepared full-length RBM38 (isoform b) as a 
recombinant GST fusion because no data are currently available on the affinity of this protein to 
target ARE sequences. As shown in Figure 5, full-length ELAVL1 and RBM38 proteins showed KD 
values of 1 nM and 0.4 nM, respectively. The value we observed with ELAVL1 is in a good 
agreement with KD values previously reported 
39. In contrast to previous reports, full-length 
ELAVL1 and GST-ORFELAVL1 did not show a significant difference in affinity for the ARE
PTMA target 
39. Similarly, we did not observe a significant difference in binding properties between full-
length RBM38 and GST-ORFRBM38 (0.4 nM vs. 1 nM, respectively). 
Validation of ARE-Interacting Domains in vivo. 
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To assess whether and to what extent the ORFs validated in vitro function in vivo, we made four 
pcDNA-based constructs (ELAVL1-, RBM38-, RALY- and R3HDM2-ORF) that allow the expression 
of V5-tagged products and used them to transfect HeLa cells. We also used a full-length ELAVL1 
construct (ELAVL1-FL) as a reference because its localization and function are supported by 
published data 41. 
First, we analyzed the transfected cells by immunofluorescence to assess the cellular 
localization of ORF products. Representative results are shown in Supplemental Figure 1. As 
expected, the ELAVL1-ORF product localized mostly in the cytoplasm of transfected cells 
because it does not include the HNS sequence, which is responsible for the nuclear localization 
of ELAVL1 41. Consistent with reported data on the cellular localization of RBM38 isoforms 35, 
the RBM38-ORF protein resulted in mostly cytosolic localization. Surprisingly, a prevalent 
nuclear/perinuclear localization of the RALY-ORF product (Supplemental Figure 1) was 
observed, although this protein does not seem to contain either a canonical nuclear localization 
signal (NLS) or the bipartite NLS element predicted by others 37. We cannot exclude the 
possibility that the protein is carried to the nucleus by interacting cargos. Finally, the R3HDM2-
ORF product showed mainly cytoplasmic localization. 
Second, we tested whether ORF-encoded domains were able to bind target mRNAs in vivo. For 
this purpose, we generated a secreted luciferase-based ARE reporter construct (secNluc-ARE) 
containing the 3’ UTR from the human -prothymosin (PTMA) gene and used it to co-transfect 
HEK293 cells with single-ORF or ELAV-FL constructs. RNP complexes were immunoprecipitated 
with an anti-V5 antibody. Immunocomplexes were split and analyzed by qRT-PCR to quantify 
the amount of bound mRNA (Figure 6A) and by Western blotting (Figure 6B) to assess the 
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effective immunoprecipitation of V5-tagged ORFs. RNA quantification is expressed as the fold 
enrichment versus the negative control (cells transfected with the empty vector). RBM38-ORF 
and ELAVL1-ORF resulted in > 50- and 3.5-fold enrichment, respectively, while no RNA 
enrichment was observed in RALY-ORF and R3HDM2-ORF immunocomplexes. Notably, these 
results reflected the affinity differences shown by the ORF products in vitro (Figure 5) and 
circumstantially support the rank differences of the selected ORFs. 
We then assessed whether ORF products can influence the metabolism of ARE-containing 
sequences in vivo by measuring luciferase activity directly from conditioned media at 24 hours 
post-transfection. As shown in Figure 6C, all constructs were able to enhance luciferase activity, 
and the ORF constructs were more effective than the ELAVL1-FL used as the positive control. 
We believe that these differences are due to a lower complexity of ORF-encoded RBDs in that 
the activity of corresponding RBPs – e.g., ELAVL1-FL – very likely reflects the interplay between 
different domains and/or other players 42. Intriguingly, RALY-ORF efficiently increased reporter 
protein expression (Figure 6C), despite its prevalent nuclear localization (supplemental Figure 
1). 
Finally, we wanted to assess if the two novel ARE-BPs interact in vivo with endogenous PTMA 
mRNA. According to reference databases (http://www.proteinatlas.org and 
(http://www.hprd.org) PTMA is expressed in HEK293T cells. Thus, we first verified the presence 
of PTMA mRNA by RT-PCR and then we transfected HEK293 cells with RALY-ORF or R3HDM2-
ORF or ELAV-FL (as positive control). Twenty-four hour following transfection, cells were cross-
linked with formaldehyde and RNP complexes were immunoprecipitated with an anti-V5 
antibody. RNA was recovered by reverse cross-linking and analyzed by qRT-PCR to quantify the 
D
ow
nl
oa
de
d 
by
 [S
IS
SA
], 
[S
tef
an
o G
us
tin
cic
h]
 at
 01
:39
 24
 N
ov
em
be
r 2
01
5 
 
 
15 
 
amount of bound PTMA mRNA with the respect to GAPDH mRNA used as a negative control. As 
shown in figure 6D, results confirm the ability of both RALY-ORF and R3HDM2-ORF products to 
bind PTMA mRNA in vivo, being R3HDM2-ORF more efficient than RALY-ORF and in accordance 
with respective affinities (fig 5C, D). 
DISCUSSION 
Here, we present a novel in vitro method that allows the identification of RBPs bound to a 
target RNA via the selection of RNA-interacting domains. Essentially, this method consists of the 
screening of a cDNA-derived ORF-filtered phage display library with a target RNA, followed by 
the deep sequencing of the ORF inserts of selected phages to identify putative positive clones. 
The result is a ranked list of genes that directs analyses and validations to the best candidates. 
Compared to other established RNA-centric methods for identifying RNA-protein interactions 
(reviewed in 5, 43, 44), RIDome has certain practical advantage (summarized in the Supplementary 
Table 1). 
First, RIDome is easy to implement and does not require mass spectrometry (MS) to identify 
RNA-interacting proteins. MS-based methods, particularly the in vivo formats, have proved to 
be powerful for revealing the complexity and dynamics of RNA-protein interactions. However, 
these methods require large amounts of starting material to purify enough protein to allow 
detection 43, 45, and despite significant improvements in MS technology, the identification of 
low-abundance RNA-protein complexes remains a major challenge. Moreover, the 
experimental setup for these approaches is generally complicated by the necessity to perform 
several parallel purifications on target or control RNAs to distinguish non-specific interactions 
and ensure the robustness of the results. In contrast, ORF-filtered display libraries are robust 
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and stable reagents that can be repeatedly screened with single or multiple RNA targets. No 
laborious and costly work is required to grow cells and prepare extracts. If unavailable, libraries 
can be constructed by established protocols 31, starting from cDNA 31, 46 or even genomic DNA 47 
and using different formats, such as phages 46, bacteria 48 or yeast 49. Library normalization and 
representativeness, which are crucial for facilitating the identification of less-expressed 
interactors, can be easily assessed by NGS analysis. When using a phage display library as 
demonstrated here, the procedure can be operationally very fast and straightforward. This 
method allows serial screenings on different target RNAs without the need to perform parallel 
experiments on negative controls because these can be used both as competitors during the 
selection process and as targets in the phage ELISA validation assays. 
Second, as is typical for display technologies, the identification and cloning of the genotypes of 
selected phages are straightforward. Moreover, we show that the cloning of discrete functional 
domains is favored by the RIDome approach. We believe this is due to the ORF-filtering step 
introduced for the library construction; random ORFs, or those encoding partial domains, do 
not fold into coherent domains and lead to aggregation, misfolding and inactivation of the 
folding reporter ß-lactamase. We believe that this feature offers significant and practical value. 
For instance, validated domains can be readily manipulated (e.g., mutagenized) to obtain 
insights into the molecular basis of RNA-protein interaction specificities or used for structural 
studies or, conversely, used for a protein-centric identification of RNA targets. 
Third, the RIDome output is a list of genes that bears some resemblance to the output from 
other RNA-centric methods used to identify RNA-protein interactions. The list can be analyzed 
using several bioinformatics tools to obtain inferences regarding cellular processes, 
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localizations or the structural/functional constrains of candidate RBPs 34, 50. Nevertheless, the 
informative power of these analyses is strictly influenced by the robustness of experimental 
results and particularly by the background level of non-specific/false positives. In this respect, 
our approach provides a practical advantage. Phage ELISA is a simple and robust assay that can 
be used as a first validation step to discriminate between specific and non-specific binders (see 
Figure 4A). Above all, it can be easily scaled up to hundreds or thousands of tests. For instance, 
as shown here (Figure 4A), it has been as simple to assess the binding specificities of known 
(RBM38 and ELAVL1) or novel (RALY and R3HDM2) ARE-RBPs as to assess the non-specific 
binding of known (TOP1 and DNAJC7) or potential (MYH9 and EIF5B) RBPs. We think that it is 
important to note that the availability of a simple and high-throughput validation assay allows 
the reconsideration of the critical challenges encountered when purifying proteins from 
complex mixtures for MS analyses. Generally, great care must be taken to find the appropriate 
stringency conditions and negative controls to minimize non-specific interactions, particularly 
for abundant proteins. This is because validation can be labor- and time-consuming and can 
depend on the availability of specific reagents. Conversely, stringency might negatively affect 
the purification of weak but significant interactors, particularly if they are novel. We believe 
that these problems are overcome, at least in part, by the RIDome approach; despite the more 
or less permissive conditions used in the selection/purification step, any candidate gene listed 
in the NGS output can be validated without the need for specific reagents and with relatively 
limited effort. This can lead to the discovery of novel RBPs or to the assignment of binding 
properties to unpredicted RBPs. 
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The limits of the RIDome approach are mainly due to its in vitro format (summarized in the 
supplementary Table 1). As with other RNA-centric in vitro approaches, a synthetic RNA is 
employed to select/purify interacting phages. Consequently, it is possible to capture only the 
subset of proteins that bind static, correctly structured sequences within the RNA bait. The 
proteins that bind structures dynamically adopted by an RNA in vivo are likely missed. 
Compared to other approaches, a further limitation of RIDome is the type of starting material – 
cell extracts versus library. Proteins that bind RNA because of the synergistic activities of other 
factors or because of post-translational modifications are likely not captured by the RIDome 
approach. 
Although in this work, aimed at tuning and validating a novel approach, the bait was an 
extensively characterized short RNA sequence/structure that has previously been employed to 
identify ARE-RBPs, we anticipate that RIDome could be a helpful complementary approach for 
identifying the repertoire of RNA-binding proteins of diverse RNA elements, such as splicing 
sites 51, mRNA localization elements (LE) 52, constitutive decay elements (CDEs) 53, RNA stability 
elements (RSEs)54 and less characterized transcripts, such as long non-coding RNAs (lncRNAs) 55. 
Overall, the RIDome approach provides an RNA-centric global assessment of RNA-RBP 
interactions via the identifications of RNA-binding domains. 
MATERIALS AND METHODS 
Biopanning procedures 
The ORF phage library used in this study has been previously described 31; the production and 
rescue of phagemids were performed according to published protocols 32. For biopanning 
experiments, phage particles were suspended in PBS buffer at a concentration of 1011 cfu/µl, 
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and for each selection, 1012 phages were used. The bait was a 3’ biotinylated RNA 
oligonucleotide corresponding to the AU-rich element of -prothymosin (AREPTMA, 5’-
GGAAAUUUGUUUGUAUUUUUAGCU-biotin). Biopanning experiments were performed as 
follows: 20 µl of streptavidin-coated magnetic beads (New England Biolabs) were washed in 
TENT Buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA, 250 mM NaCl, 0.5% Triton X-100) and then 
incubated with 1012 phages in 100 µl of TENT Buffer for 30 min at RT as a cleaning step. The 
AREPTMA oligonucleotide was diluted to 30 nM in TENT buffer containing 100 U/µl of the RNase 
inhibitor SUPERase-IN (Life Technologies), and then, 100 µl (3 pmoles) of the mixture was 
added to 20 µl of streptavidin magnetic beads and incubated for 20 min at RT. While fine-tuning 
the protocol, independent selections were performed using tRNA or ssDNA as competitors, and 
various strategies were attempted to recover bound phages (E. coli infection with or without 
RNase treatment), but we did not observe substantial differences among output ranks. Thus, as 
a standard procedure, pre-cleaned phages were added to the RNA-conjugated beads and 
incubated for 45 min at RT in the presence of 1 µg/µl tRNA or 1 µg/µl herring sperm ssDNA as 
competitors. The beads were then washed extensively in TENT buffer. The bound phages were 
eluted by infecting with 2 ml of E. coli DH5α (OD600= 0.5) at 37°C for 45 min. The amplified 
phages were used for a second cycle of selection as reported 32, 56. 
454 Deep Sequencing of cDNA Inserts 
After the second round of selection, colonies growing on agar plates were harvested, and the 
phagemid DNAs were isolated using a standard miniprep procedure. The cDNA inserts were 
processed for 454 sequencing according to the Titanium Rapid Library preparation method 
manual (Roche, Milano, Italy). The DNA library was quantified using a PicoGreen DNA 
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Quantitation Kit (Life Technologies) and checked for quality by capillary electrophoresis (Agilent 
Bioanalyzer 2100 with the High Sensitivity DNA assay kit). The DNA library was then amplified in 
emulsion following the Titanium LIB-L emPCR protocol (Roche). The reaction was recovered by 
isopropanol emulsion breaking, and the beads carrying clonally amplified DNA fragments on 
their surface were enriched. The enriched sample was loaded onto one PicoTiterPlate (PTP) and 
was sequenced according to the 454 GS-FLX Titanium protocol on the GS-Junior sequencing 
platform. 
Bioinformatics analysis 
Sequences were processed with the NGS Transcriptome profile explorer (NGS-Trex) system 
(accessible at https://www.ngs-trex.disit.unipmn.it/Trex/cms/) 33, a custom analysis workflow 
procedure mainly based on PERL scripts. Both raw and analyzed data were stored in a relational 
database. Briefly, sequences were mapped onto the human genome (NCBI build 36) using 
GMAP software, and matching sequences were compared with annotated genes. Each gene 
was then ranked according to the number of supporting sequences (defined as ‘coverage’). The 
‘depth index’ for each gene was defined as the maximum number of overlapping sequences 
(i.e., sequences supporting the same genic region). The ‘focus index,’ defined as (depth – 
1)/rank, ranged between 0 (indicating a broad distribution of sequences over the gene) and 1 
(indicating that all sequences were ‘focused’ on the same region). 
Enrichment analysis 
To implement functional enrichment, we used Gorilla (Gene Ontology enRIchment anaLysis and 
visuaLizAtion tool) for GO enrichment. A distinctive feature of GOrilla (http://cbl-
gorilla.cs.technion.ac.il) is that it allows for the identification and visualization of enriched GO 
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terms in ranked lists of genes 34. It can be run in one of two modes: (1) searching for enriched 
GO terms that appear densely at the top of a ranked list of genes (“single-ranked list” mode) or 
(2) searching for enriched GO terms in a target list of genes compared to a background list of 
genes (“two unranked lists” mode). Lists of ranked genes were retrieved from the NGS-Trex 
interface and analyzed in the “two lists of genes” running mode, using the gene list from the NS 
library as the “background” set and the gene list from the selection as the “target” set. GO 
terms with p-values < 0.001 were chosen as statistically significant terms. 
Rescue of phagemid clones by inverse PCR 
A pair of specific back-to-back outward primers was designed for each of the tested genes, 
centering on the nucleotide region identified by the overlapping reads (oligonucleotide 
sequences are provided in Additional File 3). Here, 50 ng of the phagemidic DNA minipreps was 
used as the template, and inverse PCR reactions were performed with a Phusion High-Fidelity 
DNA Polymerase (Thermo Scientific). PCR products were gel purified, phosphorylated with T4 
polynucleotide kinase, ligated by T4 DNA ligase and transformed into E. coli DH5αF′ competent 
cells. Colonies growing on ampicillin plates were randomly picked and inoculated into 1 ml 2x 
TY medium in a deep 96-well microtiter plate and grown under constant air supply using a 
custom-built air-well sparging minifermenter system 57. 
Other cloning 
For the bacterial expression of GST-fusion products, ORF fragments were excised with BssHII-
NheI from the phagemid DNA and subcloned into a custom-designed pGEX-FLAG expression 
vector as previously described 24. The vector harbors a FLAG-tag (DYKDDDDK) for the C-terminal 
tagging of expressed proteins. For the mammalian expression of the ORFs, we designed a 
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vector (pcDNA-V5-AscI/NheI) from a pcDNA3.1 backbone (Invitrogen) by cloning a cassette 
Kozak-ATG-AscI-NheI-V5 tag-stop. ORFs were subcloned as described above. The full-length (FL) 
coding sequence of human ELAVL1 was obtained by RT-PCR from HEK293T cells and cloned into 
the pCI-neo vector (Promega). ELAV-FL was epitope-tagged by replacing the terminal stop 
codon with nucleotides encoding a V5-tag (GKPIPNPLLGLD). To generate a luciferase reporter 
under the control of the α-prothymosin AU-rich element, we first removed the EGFP cassette 
from the pEGFP-C2 vector (Clontech) and replaced it with the secreted NanoLuc® luciferase 
(Promega); then, 316 bp of the 3’UTR of α-prothymosin was amplified by RT-PCR from HEK293T 
cells and cloned at the 3’ end of the secNanoLuc® cassette, generating the pCMVsecNlucARE 
vector. 
GST-fusion protein expression and purification 
ORF fragments, subcloned in pGEX-FLAG, were transformed into E. coli BL21(DE3) cells. 
Bacterial cultures (100 ml) were grown at 28°C to an OD600 = 0.5 AU, induced with 1 mM IPTG 
for 3 hours and centrifuged. Bacterial pellets were resuspended in 10 ml of lysis buffer (PBS 
containing 0.5 M NaCl, 1 mM imidazole, 200 µg/ml lysozyme, 20 µg/ml DNase, protease 
inhibitors), incubated for 30 min and sonicated for 2-3 minutes. Cell debris was removed by 
centrifugation, and the supernatants were incubated with glutathione-agarose beads (Sigma-
Aldrich) for 1 h at 4°C with gentle rotation. After three washes with 0.1% PBS-Tween and three 
with PBS, GST-fusion proteins were eluted in 750 µl of elution buffer (50 mM reduced 
glutathione, 100 mM NaCl, pH 8.0). The proteins were dialyzed against PBS and checked for 
purity and concentration by SDS-PAGE. The quantitative densitometry of proteins stained with 
Coomassie brilliant blue was performed with ImageJ software 58, using BSA as a reference for 
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protein quantification. The integrity of GST-fusion proteins was also determined by Western 
blotting using two monoclonal antibodies targeting the GST and FLAG tags (Sigma-Aldrich). 
ELISA 
The expression and testing of selected clones in ELISA-based assays, either in the phage format 
or as soluble GST-fusion polypeptides, was performed according to previously described 
standard protocols 16, with some modifications. Briefly, phage ELISA was performed with 
Microlon plates (Greiner Bio-one) coated O/N at 4°C with 10 μg/ml streptavidin. Wells were 
blocked with TENT buffer and rinsed, and then, biotinylated RNA or control DNA 
oligonucleotides (5 pmol/well, diluted in 100 µl TENT buffer containing 5 units of SUPERase) 
were captured on the plates. The phage-containing supernatants of individual clones diluted 
1:1 in TENT buffer (with 5 units of SUPERase) were added to the wells and incubated for 45 min, 
followed by incubation with HRP-conjugated anti-M13 monoclonal antibody (GE Healthcare). 
The complexes were revealed with TMB (3,3’,5,5’ tetramethylbenzidine), and the absorbance 
was read at 450 nm using a VictorTM X4 multilabel plate reader (Perkin Elmer). 
ELISA on soluble GST-fusion polypeptides was performed as follows: biotinylated 
oligonucleotides were captured on Microlon plates as described above. Wells were then 
incubated for 1 hour at RT with the purified proteins (5 pmol/well, diluted in 100 µl TENT buffer 
containing 5 units SUPERase), washed extensively with TENT buffer, incubated for 1 hour with a 
mouse monoclonal anti-GST antibody diluted 1:5,000 in TENT buffer, followed by incubation 
with an HRP-conjugated secondary antibody (Sigma-Aldrich). The bound proteins were 
examined as described above. 
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Biacore experiments 
The dynamics of RNA interactions were characterized by SPR using a BIACORE T100 instrument 
(Biacore) essentially as described 39. The oligonucleotide used in the analyses was the AREPTMA. 
The chemical biotinylation of the oligonucleotide allowed the immobilization of the RNA onto 
streptavidin-coated sensor chips (Series S Sensor Chip SA, Biacore). RNA was diluted to a final 
concentration of 1 mM in HBS buffer (10 mM HEPES, pH 7.4, 150 mM NaCl), followed by 
heating at 80°C for 10 min and cooling to room temperature. The sample was then diluted 500-
fold in running buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.025% surfactant P20; 
Biacore) and injected over the sensor chip surface at 10 µl/min at 25°C to generate an 
approximately 500 response unit (RU). The proteins were serially diluted in running buffer to 
the concentrations indicated in Figure 5 and injected at 25°C at a flow rate of 30 µl/min for 2–3 
min. Surfaces were regenerated by injecting 2 M NaCl at 50 µl/min for one minute. Analyses 
were performed in duplicate, and any background signal from a streptavidin-only reference 
flow cell was subtracted from every data set. To determine the kinetics 
(association/dissociation rate constants; ka/kd) as well as the affinities (KD) of the protein-RNA 
interactions, the data were analyzed using a two-state binding model: 1/[(ka1/kd1) x 
(1+ka2/kd2)] (ka1 and kd1 are the association and dissociation rate constants, respectively, and 
ka2 and kd2 are the forward and reverse rate constants for conformational change). 
Immunofluorescence microscopy 
HeLa cells were seeded onto glass coverslips and transfected with the respective pcDNA-V5-
ORF plasmids. At 24 hours after transfection, cells were fixed with 4% paraformaldehyde and 
4% sucrose in PBS for 15 min at RT, permeabilized with 0.2% Triton X-100 for 10 minutes and 
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blocked with 1% BSA in PBS for 30 min. The cells were incubated for 1 hour with a mouse 
monoclonal anti-V5 antibody (diluted 1:100) and then with a Cy5-conjugated secondary 
antibody (1:200, Jackson Immuno Research), and treated for 5 min with RNase A (100 μg/ml in 
PBS) followed by propidium iodide counterstaining. Images were captured with a Leica DMIRE2 
confocal fluorescence microscope equipped with Leica Confocal Software v.2.61. (Leica 
Microsystems). 
Luciferase assays and RNA immunoprecipitation (RNA-IP) 
HEK293T cells were seeded in 10-cm dishes and transiently co-transfected with 
pCMVsecNlucARE and the respective pcDNA-V5-ORF plasmids. At 24 hours after transfection, 
culture supernatants were collected and diluted 1:20, and the luciferase activity was 
determined with the Nano-Glo® Luciferase Assay (Promega) using a VictorTM X4 multilabel plate 
reader (Perkin Elmer). Cells were then collected in 1 ml RIP lysis buffer (25 mM Tris-HCl pH 7.4, 
150 mM KCl, 0.5% IGEPAL CA-630, 5 mM MgCl2, 0.5 mM DTT, protease inhibitors and 10 mM 
ribonucleoside vanadyl complex as an RNase inhibitor) and sonicated with two short pulses (15 
sec). The cell lysates were centrifuged, and the supernatants were pre-cleared with agarose 
beads. From each lysate, 50 µl was saved as “input,” and then, 3 µg of mouse monoclonal anti-
V5 antibody was added to the lysates and incubated O/N on a rotary mixer. Protein A-agarose 
beads were added and incubated for 1 hour. The beads were washed four times with RIP wash 
buffer (same as lysis buffer but with KCl increased to 300 mM for higher stringency), and then, 
RNA and proteins were eluted from the beads with TriFast reagent (Euroclone), according to 
the manufacturer’s instructions. The RNA was alcohol-precipitated using GlycoBlue (Life 
Technologies) as a co-precipitant, dissolved in 10 µl RNase-free water and reverse transcribed 
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immediately (High-Capacity cDNA reverse transcription kit, Applied Biosystems). qPCR 
amplification was performed using a CFX96 Real-Time PCR Detection System (Bio-Rad) with the 
Platinum® SYBR® Green qPCR SuperMix-UDG kit (Invitrogen). Primers were annealed to the 
NanoLuc coding sequence (sequence reported in the Additional File 3). To construct a standard 
curve, 10-fold serial dilutions of the “input” cDNA from the negative control (cells transfected 
with pCMVsecNlucARE) were used and tested in triplicate. The standard curve was plotted as the 
mean Cq values versus the log cDNA dilution. Regression analysis, standard curve slopes and 
amplification efficiencies were calculated using CFX manager™ software (Bio-Rad). Proteins 
recovered from the organic phase were dissolved in Laemmli buffer and analyzed by Western 
blotting. 
RNA immunoprecipitation of endogenous PTMA mRNA 
HEK293T cells were transfected with the respective pcDNA-V5-ORF plasmids in 10 cm dishes. 
Twenty-four hours following transfection cells were collected in PBS and cross-linked with 1% 
formaldehyde for 15 min as described 59. RNP complexes were immunoprecipitated with an 
anti-V5 antibody as above, RNA was recovered by reverse cross-linking and analyzed by qRT-
PCR to quantify the amount of bound mRNA. GAPDH was used as a negative control to estimate 
background. RNA quantification is expressed as % of RNA recovery versus input RNA. 
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Figure 1. Overview of the RIDome technology platform. A) The overall strategy consists of four 
key steps: (1) Selection of interacting ORFs on a target RNA. Displaying phages are challenged 
with a biotinylated RNA bait through two cycles of selection and amplification. (2) Massive 
sequencing of selected inserts and the ranking of reads. ORF inserts are recovered from the 
selected libraries, sequenced with 454 pyrosequencing, ranked and scored according to their 
frequency. (3) Recovery and validation in vitro of the top ranking ORFs. High-scoring ORFs are 
recloned from the library by inverse PCR, and their interactions are validated by ELISA-based 
assays. (4) In vivo validation of the interacting ORFs. RNA-binding ORFs are subcloned into a 
compatible mammalian expression vector and co-transfected in mammalian cells with a 
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reporter DNA construct harboring the target sequence. The interactions are confirmed by RNA 
immunoprecipitation and functional assays. B) The RNA baits used in the study and the 
prediction of their secondary structures with RNAfold. 
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Figure 2. Enrichment of RNA-binding ORFs after phage selection. A) RBPome coverage. To 
assess the extent of the predicted RBPome covered by our ORF library, we compared our data 
to the largest datasets of RNA-binding proteins 26 and found that 1497 RBPs (> 97%) were 
covered by at least one read. The ORF library was also compared to a dataset of 1704 
transcription factors (TFs), and we found that 1672 TFs (> 98%) were represented. B) 
Enrichment for RNA-binding proteins after phage selection. A shortened list of top-interacting 
clones was compared to the RBP and TF datasets. The selection was enriched specifically for 
RBPs. C) Functional category enrichment of selected genes. Gene ontology (GO) terms analysis 
of the 36 top selected genes was performed using GOrilla. The y-axis shows significantly (p < 
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0.001) enriched GO terms relative to Process, Function and Component, respectively, and the x-
axis shows the number of genes related to those terms. 
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Figure 3. Analysis of ELAVL1 and R3HDM2 with the NGS-Trex. The picture shows the gene 
aligned to the supporting sequences obtained before (NS) and after selection (selected). The 
blue bars at the top of each panel represent the gene, and the green boxes correspond to the 
exons (RefSeq mRNAs) of the gene. An increase in the “focus index” following phage selection 
indicates that ORFs are enriched at a single site or domain within the gene. After analysis, the 
ORF clones are recovered from the selected library by inverse PCR, using a pair of back-to-back 
specific primers centered on the sequence shared by overlapping reads. 
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Figure 4. In vitro validation of the selected RNA-binding proteins by ELISA-based assays 
A) Validation by phage ELISA. The reactivity of twelve top-ranking genes was tested on the 
AREPTMA RNA oligonucleotide. To test specificity, a mutated RNA (AREmutPTMA), an ssDNA 
oligonucleotide and streptavidin served as controls. Values are indicated as the fold signal vs. 
the background (uncoated wells). B) BLASTP analysis of ORF clones validated by GST ELISA. 
ELAVL1, RBM38, R3HDM2 and RALY contain at least one conserved RNA-binding domain. 
C) Validation by GST ELISA. Selected ORFs with positive phage ELISA results were subcloned 
into a compatible pGEX vector and purified as GST fusion proteins. Assays were performed as in 
A. 
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Figure 5. Kinetic analysis of RNA-protein interactions by SPR. Sensorgrams of ELAVL1, RBM38, 
R3HDM2 and RALY (ORFs) and ELAVL1 and RBM38 (full-length) binding to the AREPTMA RNA 
oligonucleotide are shown. Biotinylated RNA was captured on SA-coated sensor chips, and 
increasing concentrations of protein were injected over the surface. Injections were performed 
for 120 s (association phase), followed by a 300-s flow of running buffer to assess dissociation. 
The kinetic data were fitted to a two-state binding model: 1/[(ka1/kd1) x (1+ka2/kd2)], where 
ka1 and kd1 are the association and dissociation rate constants, respectively, and ka2 and kd2 
are the forward and reverse rate constants for conformational change. 
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Figure 6. In vivo validation of RBM38, ELAVL1, RALY and R3HDM2 ORFs. A, B) RNA 
immunoprecipitation. HEK293T cells were co-transfected with the ORF-V5 and the secNluc 
reporter constructs and subjected to RNA immunoprecipitation with an anti-V5 antibody. 
Following immunoprecipitation, both RNA and proteins were recovered and analyzed by A) 
qRT-PCR and B) Western blotting. C) Luciferase reporter assay. The ARE of PTMA was cloned 
downstream of the secNluc in a luciferase reporter construct and transfected into HEK293T 
cells. Twenty-four hours following transfection, cell culture supernatants were collected and 
luciferase activity was measured. D) RNA immunoprecipitation of endogenous PTMA mRNA. 
HEK293T cells were transfected with the V5-tagged ORFs. Twenty-four hour following 
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transfection, cells were cross-linked with formaldehyde and RNP complexes were 
immunoprecipitated with an anti-V5 antibody as above. RNA was recovered by reverse cross-
linking and analyzed by qRT-PCR to quantify the amount of bound mRNA. GAPDH was used as a 
negative control for background. The data are shown as the mean ± the standard error of the 
mean (n ≥ 3). 
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